Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
111470375 | 11147037 | 5 | F | 2012 | 20160720 | 20150528 | 20160728 | EXP | US-PFIZER INC-2015177045 | PFIZER | 61.00 | YR | F | Y | 129.00000 | KG | 20160728 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
111470375 | 11147037 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 3X/DAY | A482302 | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||
111470375 | 11147037 | 2 | C | REMODULIN | TREPROSTINIL | 1 | Intravenous (not otherwise specified) | 71 NG, DAILY | 0 | 71 | NG | ||||||||
111470375 | 11147037 | 3 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 20 MEQ, 1X/DAY(10 PILLS A DAY) | 0 | 20 | MEQ | QD | ||||||||
111470375 | 11147037 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, 3X/DAY | 0 | 600 | MG | TID | ||||||||
111470375 | 11147037 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
111470375 | 11147037 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
111470375 | 11147037 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
111470375 | 11147037 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
111470375 | 11147037 | 9 | C | BIOTIN | BIOTIN | 1 | 1 DF, TABLET DAILY | 0 | 1000 | MG | TABLET | ||||||||
111470375 | 11147037 | 10 | C | BIOTIN | BIOTIN | 1 | 1000 MG, 1X/DAY | 0 | 1000 | MG | TABLET | QD | |||||||
111470375 | 11147037 | 11 | C | BACLOFEN. | BACLOFEN | 1 | 10 MG, 4X/DAY | 0 | 10 | MG | QID | ||||||||
111470375 | 11147037 | 12 | C | BACLOFEN. | BACLOFEN | 1 | 0 | ||||||||||||
111470375 | 11147037 | 13 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | 300 MG, 1X/DAY | 0 | 300 | MG | QD | ||||||||
111470375 | 11147037 | 14 | C | CALCIUM/VITAMIN D3 | 2 | ((600MG CALCIUM MIXED TOGETHER WITH 400 VITAMIN D))1 DF, 3X/DAY | 0 | 600 | MG | CAPSULE | TID | ||||||||
111470375 | 11147037 | 15 | C | CALCIUM/VITAMIN D3 | 2 | 600 MG, UNK | 0 | 600 | MG | CAPSULE | TID | ||||||||
111470375 | 11147037 | 16 | C | CLARITIN | LORATADINE | 1 | 10 MG, 2X/DAY | 0 | 10 | MG | TABLET | BID | |||||||
111470375 | 11147037 | 17 | C | CRANBERRY. | CRANBERRY | 1 | 300 MG, 3X/DAY | 0 | 300 | MG | TABLET | TID | |||||||
111470375 | 11147037 | 18 | C | IRON | IRON | 1 | 65 MG, 2X/DAY | 0 | 65 | MG | BID | ||||||||
111470375 | 11147037 | 19 | C | VITAMIN C | ASCORBIC ACID | 1 | 500 MG, 2X/DAY (TWICE A DAY WITH IRON) | 0 | 500 | MG | BID | ||||||||
111470375 | 11147037 | 20 | C | VITAMIN C | ASCORBIC ACID | 1 | 500 MG, 3X/DAY | 0 | 500 | MG | TID | ||||||||
111470375 | 11147037 | 21 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | (TWO SPRAYS IN BOTH NOSE) | 0 | NASAL SPRAY | |||||||||
111470375 | 11147037 | 22 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | (HYDROCODONE 5 MG-ACETAMINOPHEN 325 MG ONE EVERY SIX HOURS), AS NEEDED | 0 | |||||||||||
111470375 | 11147037 | 23 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
111470375 | 11147037 | 24 | C | LASIX | FUROSEMIDE | 1 | 40 MG, TABLET 3 EVERY MORNING, ADDITIONAL 80MG IF GAIN WEIGHT | 0 | TABLET | ||||||||||
111470375 | 11147037 | 25 | C | LASIX | FUROSEMIDE | 1 | 160 MG, 1X/DAY | 0 | 160 | MG | TABLET | QD | |||||||
111470375 | 11147037 | 26 | C | METOLAZONE. | METOLAZONE | 1 | 2.5 MG, EVERY THIRD | 0 | 2.5 | MG | |||||||||
111470375 | 11147037 | 27 | C | METOLAZONE. | METOLAZONE | 1 | 0 | ||||||||||||
111470375 | 11147037 | 28 | C | METOPROLOL SUCCINATE ER | METOPROLOL SUCCINATE | 1 | 1 DF, DAILY | 0 | 1 | DF | |||||||||
111470375 | 11147037 | 29 | C | NIACIN ER | NIACIN | 1 | 500 MG, 1X/DAY | 0 | 500 | MG | TABLET | QD | |||||||
111470375 | 11147037 | 30 | C | NYSTATIN. | NYSTATIN | 1 | UNK, AS NEEDED | 0 | OINTMENT | ||||||||||
111470375 | 11147037 | 31 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 500 MG, 1X/DAY | 0 | 500 | MG | TABLET | QD | |||||||
111470375 | 11147037 | 32 | C | MULTIVITAMINS | VITAMINS | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
111470375 | 11147037 | 33 | C | AMIODARONE HCL | AMIODARONE HYDROCHLORIDE | 1 | 100 MG, DAILY | 0 | 100 | MG | |||||||||
111470375 | 11147037 | 34 | C | BUMEX | BUMETANIDE | 1 | 2.5 MG, EVERY THIRD | 0 | 2.5 | MG | |||||||||
111470375 | 11147037 | 35 | C | COUMADIN | WARFARIN SODIUM | 1 | 7.5 MG, DAILY(TAKE 1 PILL EVERY DAY EXCEPT WED WHICH IS HALF A PILL) | 0 | 7.5 | MG | |||||||||
111470375 | 11147037 | 36 | C | SUPER B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | UNK (500MG TAKE WITH IRON AND VITAMIN C TWICE A DAY) | 0 | |||||||||||
111470375 | 11147037 | 37 | C | SUPER B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
111470375 | 11147037 | 38 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | 100 MG, AS NEEDED | 0 | 100 | MG | |||||||||
111470375 | 11147037 | 39 | C | LORATADINE. | LORATADINE | 1 | 10 MG, 2X/DAY | 0 | 10 | MG | BID | ||||||||
111470375 | 11147037 | 40 | C | POLYETHYLENE GLYCOL | POLYETHYLENE GLYCOLS | 1 | 255 G, UNK | 0 | 255 | G | |||||||||
111470375 | 11147037 | 41 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | Nasal | UNK, DAILY (100MCG 2 SPRAY EACH NOSTRIL DAILY PRN) | 0 | 100 | UG | NASAL SPRAY | |||||||
111470375 | 11147037 | 42 | C | OXYGEN. | OXYGEN | 1 | UNK | 0 | |||||||||||
111470375 | 11147037 | 43 | C | METOPROLOL. | METOPROLOL | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
111470375 | 11147037 | 44 | C | HYDROCODONE | HYDROCODONE | 1 | UNK UNK, 2X/DAY(5/325)(SHE CAN TAKE IT BID AND SHE USUALLY TAKE IT ONCE A DAY AT NIGHT) | 0 | BID | ||||||||||
111470375 | 11147037 | 45 | C | SLO-NIACIN | DIETARY SUPPLEMENT | 1 | 500 MG, 1X/DAY | 0 | 500 | MG | QD | ||||||||
111470375 | 11147037 | 46 | C | NYSTATIN. | NYSTATIN | 1 | UNK, AS NEEDED | 0 | |||||||||||
111470375 | 11147037 | 47 | C | CARTIA XT | DILTIAZEM HYDROCHLORIDE | 1 | 240 MG, 1X/DAY | 0 | 240 | MG | QD | ||||||||
111470375 | 11147037 | 48 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 40 MG, 4X/DAY | 0 | 40 | MG | QID | ||||||||
111470375 | 11147037 | 49 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 50 MG, 2X/DAY | 0 | 50 | MG | BID | ||||||||
111470375 | 11147037 | 50 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
111470375 | 11147037 | 51 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 40 MG, 2X/DAY | 0 | 40 | MG | BID | ||||||||
111470375 | 11147037 | 52 | C | RANITIDINE. | RANITIDINE | 1 | 75 MG, 2X/DAY | 0 | 75 | MG | BID | ||||||||
111470375 | 11147037 | 53 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | 15 MG, 1X/DAY | 0 | 15 | MG | QD | ||||||||
111470375 | 11147037 | 54 | C | CALCIUM | CALCIUM | 1 | 600 MG, 3X/DAY | 0 | 600 | MG | TID | ||||||||
111470375 | 11147037 | 55 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | UNK, AS NEEDED | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
111470375 | 11147037 | 1 | Pulmonary arterial hypertension |
111470375 | 11147037 | 2 | Pulmonary hypertension |
111470375 | 11147037 | 3 | Mineral supplementation |
111470375 | 11147037 | 4 | Post polio syndrome |
111470375 | 11147037 | 5 | Neuropathy peripheral |
111470375 | 11147037 | 6 | Diabetes mellitus |
111470375 | 11147037 | 7 | Pain |
111470375 | 11147037 | 8 | Muscle spasms |
111470375 | 11147037 | 9 | Hair growth abnormal |
111470375 | 11147037 | 10 | Nail growth abnormal |
111470375 | 11147037 | 11 | Muscle spasms |
111470375 | 11147037 | 12 | Catheter placement |
111470375 | 11147037 | 13 | Atrial fibrillation |
111470375 | 11147037 | 14 | Osteoporosis |
111470375 | 11147037 | 17 | Urinary tract infection |
111470375 | 11147037 | 21 | Nasal discomfort |
111470375 | 11147037 | 22 | Pain |
111470375 | 11147037 | 24 | Cardiac failure congestive |
111470375 | 11147037 | 26 | Cardiac failure congestive |
111470375 | 11147037 | 27 | Cardiac disorder |
111470375 | 11147037 | 28 | Atrial fibrillation |
111470375 | 11147037 | 29 | Blood cholesterol increased |
111470375 | 11147037 | 30 | Fungal infection |
111470375 | 11147037 | 31 | Diabetes mellitus |
111470375 | 11147037 | 33 | Arrhythmia |
111470375 | 11147037 | 34 | Cardiac failure congestive |
111470375 | 11147037 | 35 | Pulmonary hypertension |
111470375 | 11147037 | 36 | Anaemia |
111470375 | 11147037 | 38 | Faeces soft |
111470375 | 11147037 | 39 | Antiallergic therapy |
111470375 | 11147037 | 40 | Diarrhoea |
111470375 | 11147037 | 43 | Atrial fibrillation |
111470375 | 11147037 | 44 | Pain |
111470375 | 11147037 | 45 | Blood cholesterol |
111470375 | 11147037 | 46 | Fungal infection |
111470375 | 11147037 | 53 | Urinary tract infection |
111470375 | 11147037 | 54 | Osteoporosis |
111470375 | 11147037 | 55 | Faeces soft |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
111470375 | 11147037 | HO |
111470375 | 11147037 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
111470375 | 11147037 | Abnormal faeces | |
111470375 | 11147037 | Ankle fracture | |
111470375 | 11147037 | Arrhythmia | |
111470375 | 11147037 | Atrial fibrillation | |
111470375 | 11147037 | Back pain | |
111470375 | 11147037 | Depressed mood | |
111470375 | 11147037 | Dizziness | |
111470375 | 11147037 | Emotional disorder | |
111470375 | 11147037 | Fall | |
111470375 | 11147037 | Femur fracture | |
111470375 | 11147037 | Fibula fracture | |
111470375 | 11147037 | Gastrointestinal haemorrhage | |
111470375 | 11147037 | Haemorrhage | |
111470375 | 11147037 | Herpes zoster | |
111470375 | 11147037 | Hypotension | |
111470375 | 11147037 | Impaired healing | |
111470375 | 11147037 | Lower limb fracture | |
111470375 | 11147037 | Pain in extremity | |
111470375 | 11147037 | Pulmonary embolism | |
111470375 | 11147037 | Pulmonary hypertension | |
111470375 | 11147037 | Supraventricular tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
111470375 | 11147037 | 42 | 2008 | 0 |